Primary Structure: How Sequence Defines Peptide Identity

Scientific Snapshot

Discipline: Peptide Chemistry
Difficulty: Intermediate
Course position: Lesson 4 of 15
Core concepts: sequence, residue numbering, termini, modifications, sequence variants, identity confirmation.

Learning Objectives

Readers should be able to:

• Define primary structure.
• Explain sequence direction and numbering.
• Describe terminal and side-chain modifications.
• Distinguish composition from sequence.
• Understand why intact mass alone may be insufficient for full identity confirmation.

Executive Summary

Primary structure is the exact linear order of amino-acid residues together with defined terminal states, stereochemistry, and covalent modifications.

A sequence is not fully specified until the following are clear:

• residue order,
• N-terminal state,
• C-terminal state,
• stereochemistry,
• disulfide connectivity where applicable,
• side-chain modifications,
• isotopic or reporter labels.

Two molecules may share the same amino-acid composition and molecular mass while differing in residue order or stereochemistry.

Sequence Direction

Sequences are written from N-terminus to C-terminus.

Residues are numbered in that direction unless another convention is explicitly defined.

Consistent numbering is essential for:

• modification mapping,
• impurity naming,
• sequence comparison,
• peptide mapping,
• MS/MS interpretation.

One-Letter and Three-Letter Codes

Amino acids may be represented with one-letter or three-letter abbreviations.

One-letter codes are compact. Three-letter codes reduce ambiguity for readers less familiar with sequence notation.

Noncanonical residues require explicit definitions.

Terminal States

Common N-terminal states include:

• free amine,
• acetylation,
• pyroglutamate formation,
• linker-derived modifications.

Common C-terminal states include:

• free carboxylic acid,
• amide,
• ester,
• specialized conjugates.

Terminal changes alter molecular mass, charge, stability, and chromatographic behavior.

Covalent Modifications

Primary structure includes covalent modifications such as:

• phosphorylation,
• oxidation,
• glycosylation,
• lipidation,
• PEGylation,
• cyclization,
• disulfide bonds,
• fluorophores,
• affinity tags.

Sequence Variants and Impurities

Potential variants include:

• deletion sequences,
• truncations,
• insertions,
• residue substitutions,
• epimers,
• positional isomers,
• incompletely deprotected species.

Some variants show different intact mass. Others do not.

Calculating Molecular Mass

Mass calculation should account for:

• residue masses,
• loss of water during bond formation,
• terminal groups,
• disulfide formation,
• covalent modifications,
• isotope convention.

Average mass and monoisotopic mass serve different analytical purposes.

Sequence Confirmation

Intact Mass

Confirms agreement with expected mass but cannot always establish order or stereochemistry.

Tandem MS

Fragmentation supports residue order by generating sequence-informative ion series.

Peptide Mapping

Useful for larger molecules or modified sequences.

Amino-Acid Analysis

Supports composition but not order.

NMR

May provide structural evidence for smaller peptides or specific modifications.

Primary Structure and HPLC

Sequence order changes hydrophobic surface presentation, charge distribution, and conformation. Isomeric sequences may therefore show different retention even when their masses match.

Primary Structure and Stability

Sequence reveals likely liabilities:

• methionine oxidation,
• asparagine deamidation,
• cysteine disulfide chemistry,
• aspartic-acid isomerization,
• terminal cyclization,
• aggregation-prone hydrophobic regions.

Science Makes Sense

Primary structure is the peptide’s exact spelling.

Using the right letters in the wrong order creates a different word. The same is true for amino acids: composition alone is not identity.

Common Misconceptions

“The sequence is complete if the residue order is known.”

Terminal groups, stereochemistry, and covalent modifications must also be defined.

“Correct mass proves correct sequence.”

Sequence isomers and stereoisomers may share mass.

“Amino-acid analysis confirms sequence.”

It confirms composition, not order.

Laboratory Best Practices

• Use an unambiguous sequence format.
• Define termini and modifications.
• Record stereochemistry for nonstandard residues.
• Maintain a theoretical-mass calculation sheet.
• Confirm identity with orthogonal evidence.
• Link impurity names to specific structural hypotheses.
• Use consistent residue numbering across reports.

Frequently Asked Questions

What is primary structure?

The exact linear amino-acid sequence together with defined covalent features.

Does disulfide connectivity count as primary structure?

It is a covalent structural feature and should be explicitly documented.

Why can two sequences share a mass?

They may contain the same residue composition in a different order.

What does MS/MS add beyond intact mass?

It provides fragment evidence related to residue order.

Why do terminal modifications matter?

They alter mass, charge, stability, and interactions.

Key Takeaways

• Primary structure defines peptide identity at the covalent level.
• Sequence direction is N-to-C.
• Termini, stereochemistry, and modifications must be specified.
• Intact mass is necessary evidence but may not be sufficient.
• Sequence knowledge predicts analytical and stability behavior.

Suggested Figures

1. Sequence notation and numbering.
2. Free versus modified termini.
3. Same composition, different sequence.
4. Intact mass versus MS/MS evidence.
5. Common sequence-related impurities.
6. Sequence-to-stability risk map.

Knowledge Check

1. Why is sequence direction important?
2. Name two terminal modifications.
3. Why can intact mass fail to distinguish sequence variants?
4. What does amino-acid analysis establish?
5. How can sequence predict degradation risk?

References

1. Biemann K. Sequencing of peptides by tandem mass spectrometry.
2. Gross JH. Mass Spectrometry: A Textbook.
3. Nelson DL, Cox MM. Lehninger Principles of Biochemistry.
4. ICH Q2(R2). Validation of Analytical Procedures.

Editorial Note

Version 1.0 establishes the identity framework used throughout synthesis, characterization, and quality-control monographs.